Correlation between perceived quality of life among patients with Pulmonary Arterial Hypertension, the 6-minute walking test and the risk stratification.

A. Martinez Meñaca (Santander, Spain), I. Fernandez-Cuesta Peñafiel (Madrid, Spain), I. Blanco Vich (Barcelona, Spain), A. Roman Broto (Barcelona, Spain), J. Cifrian Martinez (Santander, Spain), P. Escribano Subias (Madrid, Spain), P. Bedate Diaz (Oviedo, Spain)

Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Session: Pulmonary arterial hypertension: recent advances from the bedside
Session type: Poster Discussion
Number: 5470
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Martinez Meñaca (Santander, Spain), I. Fernandez-Cuesta Peñafiel (Madrid, Spain), I. Blanco Vich (Barcelona, Spain), A. Roman Broto (Barcelona, Spain), J. Cifrian Martinez (Santander, Spain), P. Escribano Subias (Madrid, Spain), P. Bedate Diaz (Oviedo, Spain). Correlation between perceived quality of life among patients with Pulmonary Arterial Hypertension, the 6-minute walking test and the risk stratification.. 5470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015

Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 16s
Year: 2005

Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

Investigation of clinic measurements of six minute walk test and stair-climbing test in patients with mild COPD
Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods
Year: 2015

The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Reproducibility of 6-minute walking test in patients with COPD
Source: Eur Respir J 2011; 38: 261-267
Year: 2011



The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 487-494
Year: 2013



Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Clinical exercise physiology in health and disease
Year: 2016


Assessment of parameters of lung ventilation during 6-minute walk test in patients with COPD
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016

Pulmonary rehabiltation: COPD severity and improvement in walking distance
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004

Determinants of the Glittre ADL test in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014


Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Baseline determinants of 1-minute sit-to-stand test performance in COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015


Improvement of 6-minutes walking test (6MWT) and pulmonary functional status after an inpatient pulmonary rehabilitation program (PRP) in moderate-severe and severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004

Assessment of relation among emotional status, pulmonary function test, exercise performance, and quality of life in patients with COPD
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007


Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Six-minute walk distance targets in elderly IPAH patients – Consideration of predicted values
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013